FindTrial
Sign In

Clinical evaluation of NKQ-01in patients with cancer-related breakthrough pain

Clinical evaluation of NKQ-01in patients with cancer-related breakthrough pain

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080221212
Enrollment
Unknown
Registered
2010-08-19
Start date
2010-08-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer-related Breakthrough Pain

Interventions

investigational material(s) Generic name etc : NKQ-01 INN of investigational material : Therapeutic category code : 114 Antipyretics, analgesics and anti-inflammatory agents Dosage and Administration

Sponsors

Nippon Kayaku Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The cancer-related breakthrough pain which rescue needs

Exclusion criteria

Exclusion criteria:

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026